Inhibitors of CD147, a transmembrane glycoprotein, and TFPI, a natural inhibitor of the coagulation pathway, have shown potential implications for inhibiting tumor progression, metastasis, and chemoresistance [17–19]. Here, TFPI is linked to neoplasm.